Skip to content

Nuvation Bio NUVB Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
-$112.99M-35.0%
Immunome logo
ImmunomeIMNM
-$53.84M-29.1%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-$43.6M+32.1%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$101.3M-41.9%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$45.85M-14.6%
Summit Therapeutics logo
Summit TherapeuticsSMMT
-$189.52M-200%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's comprehensive income (loss), net of tax, attributable to parent?
Nuvation Bio (NUVB) reported comprehensive income (loss), net of tax, attributable to parent of $3.91M in Q1 2026.
How has Nuvation Bio's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
Nuvation Bio's comprehensive income (loss), net of tax, attributable to parent increased by 107.3% year-over-year, from -$53.26M to $3.91M.
What is the long-term trend for Nuvation Bio's comprehensive income (loss), net of tax, attributable to parent?
Over 4 years (2021 to 2025), Nuvation Bio's comprehensive income (loss), net of tax, attributable to parent has grown at a 23.0% compound annual growth rate (CAGR), from -$89.59M to -$205.39M.
What does comprehensive income (loss), net of tax, attributable to parent mean?
This metric represents the total change in equity from non-owner sources, including net income and other items such as foreign currency translation adjustments and unrealized gains or losses on securities. It provides a more holistic view of the company's financial performance beyond the traditional income statement. Investors use this to evaluate the overall impact of market and economic factors on the company's total shareholder value.